Anemia
News
Inhibitor receives orphan designation for ITP
The U.S.
News
‘Intense’ end-of-life care may be common in HSCT recipients
Patients who die within a year of allogeneic hematopoietic stem cell transplant (HSCT) tend to receive “medically intense” end-of-life care, an...
News
FDA approves DNA-based blood type test
This is the first molecular-based test for red blood cell types to report genotypes in its results.
News
Crizanlizumab appears effective across subgroups
Crizanlizumab can reduce vaso-occlusive crises (VOCs) across subgroups of patients with sickle cell disease (SCD), according to a post-hoc...
From the Journals
Crizanlizumab relieves sickle cell crises across subgroups
The post hoc analysis of the SUSTAIN trial showed a significant decrease in painful vaso-occlusive crises.
News
Variant not associated with CLL, AIHA, or ITP in certain patients
DUBROVNIK, CROATIA—New research suggests there is no association between the PTPN22 R620W polymorphism and chronic lymphocytic leukemia (CLL) or...
News
Researchers develop genetics-based prognostic tool for MDS
Researchers have developed a new risk model for primary myelodysplastic syndromes (MDS) that integrates genetic and clinical information. The...
Latest News
NHLBI commits to a sickle cell cure
A “circle of partners” seeks to bring best practices to all corners of the world while pushing for a cure.
News
CHMP backs proposed biosimilars of pegfilgrastim
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval for three proposed biosimilars of...
News
Sequencing informs prognosis after HSCT in MDS
Gene sequencing early after transplant may provide important prognostic information in patients with myelodysplastic syndromes (MDS), according to...
News
HIF1A could be therapeutic target for MDS
The transcription factor HIF1A could be a therapeutic target for “a broad spectrum” of patients with myelodysplastic syndromes (MDS), according to...